ONL Therapeutics
PrivateLast Round
Series D
Sep 13, 2024
Total Funding Raised
$135.15M
Company Overview
ONL Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments for serious retinal diseases and conditions to protect and enhance patients' vision.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ONL Therapeutics Comps
Public and private peers based on sector, stage, and business model.
ONL Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 13, 2024 | ||||
| Series C | Aug 1, 2023 | ||||
| Series B | Dec 22, 2020 | ||||
| Convertible Debt | Aug 22, 2019 | ||||
| Series A | May 17, 2017 | ||||
Convertible Debt | Mar 21, 2017 |
Key People
Founding team and executive leadership
ONL Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Series C, Series B |
| Hestia Investments | Series A |
| Novartis Venture Fund | Series D |
| Biosciences Research & Commercialization Center | Convertible Debt, Series B, Series A |
| Mayewell Capital | Series C |
| Michigan Capital Network | Series B |
| Capital Community Angel Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Presented at the FLORetina-ICOOR Congress 2025.
- Nov 10, 2025
Will present at the EYENOVATE conference.
ONL Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ONL Therapeutics's valuation, stock price, and market status.
